Loading company
Latest annual · FY2025
Millions- Total revenues
- 62
- Gross profit
- 41
- Operating income
- (8)
- Net income
- (11)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 19
- Gross profit
- 13
- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -5.7%
- Revenue, 5 yearsFY2020 to FY2025
- +6.8%
- Net income, 5 yearsFY2020 to FY2025
- n/m
Journey Medical Corp (DERM) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $61.9 million | $56.1 million | +10.2% | 10-K 2026-03-26 · proof |
| Gross profit | $40.9 million | $35.3 million | +16.1% | 10-K 2026-03-26 · proof |
| Operating income | -$8.2 million | -$13.7 million | 10-K 2026-03-26 · proof | |
| Net income | -$11.4 million | -$14.7 million | 10-K 2026-03-26 · proof | |
| Cash from operating activities | -$12.4 million | -$9.1 million | 10-K 2026-03-26 · proof | |
| Total assets | $94.6 million | $80.2 million | +17.9% | 10-K 2026-03-26 · proof |
| Total liabilities | $62.7 million | $60.2 million | +4.3% | 10-K 2026-03-26 · proof |
| Cash and cash equivalents | $24.1 million | $20.3 million | +18.6% | 10-K 2026-03-26 · proof |
- What was Journey Medical Corp (DERM)'s revenue in fiscal 2025?
- Journey Medical Corp (DERM) reported revenue of $61.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $56.1 million the year before (+10.2%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was Journey Medical Corp (DERM)'s gross profit in fiscal 2025?
- Journey Medical Corp (DERM) reported gross profit of $40.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $35.3 million the year before (+16.1%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was Journey Medical Corp (DERM)'s operating income in fiscal 2025?
- Journey Medical Corp (DERM) reported operating income of -$8.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$13.7 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was Journey Medical Corp (DERM)'s net income in fiscal 2025?
- Journey Medical Corp (DERM) reported net income of -$11.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$14.7 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was Journey Medical Corp (DERM)'s cash from operating activities in fiscal 2025?
- Journey Medical Corp (DERM) reported cash from operating activities of -$12.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$9.1 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are Journey Medical Corp (DERM)'s total assets?
- As of Dec 31, 2025, Journey Medical Corp (DERM) reported total assets of $94.6 million, against $80.2 million a year earlier (+17.9%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are Journey Medical Corp (DERM)'s total liabilities?
- As of Dec 31, 2025, Journey Medical Corp (DERM) reported total liabilities of $62.7 million, against $60.2 million a year earlier (+4.3%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are Journey Medical Corp (DERM)'s cash and cash equivalents?
- As of Dec 31, 2025, Journey Medical Corp (DERM) reported cash and cash equivalents of $24.1 million, against $20.3 million a year earlier (+18.6%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:DERM&period_type=annual&limit=5"Information only, not investment advice.